ACIP Recommends 2nd COVID-19 Shot for Older Adults, Immunocompromised Individuals.

The US CDC's Advisory Committee on Immunization Practices (ACIP) recommended that adults aged 65 years and older and moderately or severely immunocompromised individuals receive a second dose of the 2024-2025 COVID-19 vaccine 6 months after their first dose. Additionally, individuals who are moderately or severely immunocompromised should receive 3 or more doses under shared clinical decision making. CDC Director Mandy Cohen endorsed these recommendations, emphasizing the importance of updated vaccinations to reduce the risk of severe illness from COVID-19. The ACIP also recommended lowering the age for vaccination against invasive pneumococcal disease and pneumococcal pneumonia from 65 to 50 years, advising all adults aged 50 and older to receive specific vaccines. [Extracted from the article]

Copyright of Patient Care (Online) is the property of MJH Life Sciences and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)